Valuation: Stille AB

Market Cap 224.19Cr 22Cr 20Cr 19Cr 17Cr 32Cr 2.14TCr 32Cr 88Cr 1.1TCr 84Cr 82Cr 3.55TCr P/E 2026 *
26.8x
P/E 2027 * 20.5x
Enterprise Value 218.21Cr 22Cr 19Cr 18Cr 16Cr 31Cr 2.08TCr 31Cr 85Cr 1.07TCr 82Cr 80Cr 3.45TCr EV / Sales 2026 *
2.99x
EV / Sales 2027 * 2.61x
Free-Float
53.19%
Yield 2026 *
-
Yield 2027 * 0.8%
1 day-2.61%
1 week-2.21%
Current month-1.62%
1 month+1.67%
3 months-6.18%
6 months+8.97%
Current year+23.98%
1 week 243
Extreme 243
255
1 month 232.5
Extreme 232.5
260
Current year 143
Extreme 143
283
1 year 143
Extreme 143
283
3 years 94.2
Extreme 94.2
283
5 years 94.2
Extreme 94.2
283
10 years 37.5
Extreme 37.5
283
Manager TitleAgeSince
Chief Executive Officer 48 12/05/2025
Director of Finance/CFO 54 08/12/2025
Chief Operating Officer - 02/01/2026
Director TitleAgeSince
Director/Board Member 66 01/01/2000
Director/Board Member 63 01/01/2021
Director/Board Member 62 01/01/2023
Date Insider Type Main position Quantity % Market Cap. Importance
27/05/26 Buy

Chief Operating Officer

1,197 0.0133%
30/04/26 Sell 8,049 0.0896%
10/03/26 Sell

Director

2,750 0.0306%
Change 5-day change 1-year change 3-year change Capi.($)
-2.61%-2.21%+22.42%+141.79% 22Cr
-0.79%+2.96%-23.07%+11.22% 18TCr
-1.66%+4.56%-4.73%+26.54% 12TCr
-1.32%+1.15%-22.89%+9.12% 11TCr
-1.19%-1.16%-47.20%-11.64% 7.53TCr
+0.82%+4.00%+3.80%+74.11% 6.2TCr
+1.04%+0.06%+19.35%+61.96% 5.28TCr
-1.56%+3.44%-0.09%-27.91% 5.15TCr
-1.38%+0.71%-18.04%+21.80% 4.13TCr
-2.01%-0.96% - - 3.14TCr
Average -1.04%+2.05%-7.83%+34.11% 7.17TCr
Weighted average by Cap. -0.91%+2.16%-14.80%+18.35%

Financials

2026 *2027 *
Net sales 73Cr 7.27Cr 6.51Cr 6.07Cr 5.5Cr 10Cr 695.21Cr 10Cr 29Cr 358.76Cr 27Cr 27Cr 1.15TCr 80Cr 8Cr 7.16Cr 6.68Cr 6.06Cr 11Cr 765Cr 11Cr 31Cr 394.77Cr 30Cr 29Cr 1.27TCr
Net income 8.36Cr 83.33L 74.6L 69.54L 63.07L 1.19Cr 80Cr 1.2Cr 3.27Cr 41Cr 3.13Cr 3.06Cr 132.28Cr 11Cr 1.09Cr 97.41L 90.81L 82.36L 1.55Cr 104.02Cr 1.56Cr 4.27Cr 54Cr 4.09Cr 4Cr 172.73Cr
Net Debt -5.98Cr -59.64L -53.39L -49.77L -45.14L -85.14L -57Cr -85.67L -2.34Cr -29Cr -2.24Cr -2.19Cr -95Cr -15Cr -1.46Cr -1.31Cr -1.22Cr -1.1Cr -2.08Cr -139.45Cr -2.1Cr -5.73Cr -72Cr -5.48Cr -5.36Cr -231.57Cr
Projected Income Statement - Annual - Stille AB
Logo Stille AB
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Employees
225
Date Price Change Volume
13/26/13 SEK 243.00 -2.61% 1,935
12/26/12 SEK 249.50 0.00% 3,124
09/26/09 SEK 249.50 -0.20% 1,785
08/26/08 SEK 250.00 -0.20% 12,187
07/26/07 SEK 250.50 +0.80% 5,653
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Stille AB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
249.50SEK
Average target price
287.00SEK
Spread / Average Target
+15.03%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Stille AB
  1. Stock Market
  2. Stocks
  3. STIL Stock